Seth Klarman
Baupost Group
Seth Klarman TRANSLATE BIO INC stake
total: 272
Baupost Group TBIO-OLD trades
- Total transactions:
- 7
- New positions:
- 1
- Sold out:
- 1
- Added:
- 5
- Held since:
- 2018 Q2
- Held for:
- 13 quarters
- Latest activity:
- 2021 Q3
According to 2026 Q2 report, Seth Klarman doesn't hold any TRANSLATE BIO INC (TBIO-OLD) shares. To date, the estimated cost basis is nearly $10.62 for "buy" trades and estimated average "sell" price is $27.35. Baupost Group first purchased TBIO-OLD in 2018 Q2, initially acquiring about 1.92M shares. Since the initial investment in TRANSLATE BIO INC (TBIO-OLD), Baupost Group has made 6 more transactions.
When did Seth Klarman sell TRANSLATE BIO INC (TBIO-OLD)?
Seth Klarman sold off the entire TRANSLATE BIO INC (TBIO-OLD) position in 2021 Q3.
When did Seth Klarman buy TRANSLATE BIO INC (TBIO-OLD)?
Seth Klarman first invested in TRANSLATE BIO INC (TBIO-OLD) in 2018 Q2 at the reported quarter-end price of $12.65 per share.
What's the cost basis of Baupost Group's TBIO-OLD stake?
The estimated cost basis for TRANSLATE BIO INC (TBIO-OLD) stake is around $10.62 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $10.62
- Weighted AVG sell price:
- $27.35
Seth Klarman's historical trades in TRANSLATE BIO INC
7 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2021 Q3
|
0.00%
|
0
|
$27.35
|
|
-100% (-18,044,239)
|
-4%
|
|
2020 Q2
|
3.98%
|
$17.69
|
+2.85% (+500,000)
|
|||
|
2019 Q3
|
1.95%
|
$9.82
|
+98.37% (+8,700,000)
|
|||
|
2019 Q2
|
0.99%
|
$12.37
|
+36.25% (+2,352,941)
|
|||
|
2019 Q1
|
0.54%
|
$9.85
|
+0.00% (+11)
|
|||
|
2018 Q3
|
0.48%
|
$9.61
|
+237.55% (+4,568,211)
|
|||
|
2018 Q2
|
0.21%
|
$12.65
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.